{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T17:18:39Z","timestamp":1795281519610,"version":"4.10.3"},"reference-count":47,"publisher":"BMJ","issue":"1","funder":[{"name":"Dr. Franklin M. Klion Young Scientist Research Award","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["PERIS (SLT017\/20\/000206)"],"award-info":[{"award-number":["PERIS (SLT017\/20\/000206)"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA196521"],"award-info":[{"award-number":["P30-CA196521"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PhD Scientist Innovative Research Award","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Rio Hortega grant (CM19\/00039)"],"award-info":[{"award-number":["Rio Hortega grant (CM19\/00039)"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001384","name":"Samuel Waxman Cancer Research Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001384","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Acad\u00e8mia de Ci\u00e8ncies M\u00e8diques i de la Salut de Catalunya i de Balears","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["HUNTER, Ref. C9380\/A26813"],"award-info":[{"award-number":["HUNTER, Ref. C9380\/A26813"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["HUNTER, Ref. C9380\/A26813"],"award-info":[{"award-number":["HUNTER, Ref. C9380\/A26813"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA150272P3"],"award-info":[{"award-number":["CA150272P3"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tisch Cancer Institute","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["HEPCAR, Ref. 667273-2"],"award-info":[{"award-number":["HEPCAR, Ref. 667273-2"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG: HA 8754\/1-1"],"award-info":[{"award-number":["DFG: HA 8754\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["CLJUN20007CAST"],"award-info":[{"award-number":["CLJUN20007CAST"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["HUNTER, Ref. C9380\/A26813"],"award-info":[{"award-number":["HUNTER, Ref. C9380\/A26813"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","doi-asserted-by":"publisher","award":["SAF2016-76390"],"award-info":[{"award-number":["SAF2016-76390"]}],"id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["SGR-1358"],"award-info":[{"award-number":["SGR-1358"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK128289"],"award-info":[{"award-number":["R01 DK128289"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-128289"],"award-info":[{"award-number":["R01-128289"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-56621"],"award-info":[{"award-number":["R01-56621"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2022,2,4]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We previously reported a characterisation of the hepatocellular carcinoma (HCC) immune contexture and described an immune-specific class. We now aim to further delineate the immunogenomic classification of HCC to incorporate features that explain responses\/resistance to immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We performed RNA and whole-exome sequencing, T-cell receptor (TCR)-sequencing, multiplex immunofluorescence and immunohistochemistry in a novel cohort of 240 HCC patients and validated our results in other cohorts comprising 660 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our integrative analysis led to define: (1) the inflamed class of HCC (37%), which includes the previously reported immune subclass (22%) and a new immune-like subclass (15%) with high interferon signalling, cytolytic activity, expression of immune-effector cytokines and a more diverse T-cell repertoire. A 20-gene signature was able to capture ~90% of these tumours and is associated with response to immunotherapy. Proteins identified in liquid biopsies recapitulated the inflamed class with an area under the ROC curve (AUC) of 0.91; (2) The intermediate class, enriched in\n                      <jats:italic>TP53<\/jats:italic>\n                      mutations (49% vs 29%, p=0.035), and chromosomal losses involving immune-related genes and; (3) the excluded class, enriched in\n                      <jats:italic>CTNNB1<\/jats:italic>\n                      mutations (93% vs 27%, p&lt;0.001) and\n                      <jats:italic>PTK2<\/jats:italic>\n                      overexpression due to gene amplification and promoter hypomethylation.\n                      <jats:italic>CTNNB1<\/jats:italic>\n                      mutations outside the excluded class led to weak activation of the Wnt-\u03b2catenin pathway or occurred in HCCs dominated by high interferon signalling and type I antigen presenting genes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We have characterised the immunogenomic contexture of HCC and defined inflamed and non-inflamed tumours. Two distinct\n                      <jats:italic>CTNNB1<\/jats:italic>\n                      patterns associated with a differential role in immune evasion are described. These features may help predict immune response in HCC.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2021-325918","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:30:23Z","timestamp":1645623023000},"page":"129-140","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":252,"title":["Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification"],"prefix":"10.1136","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1453-2193","authenticated-orcid":false,"given":"Carla","family":"Montironi","sequence":"first","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, Universitat de Barcelona, Barcelona, Spain"},{"name":"Pathology Department & Molecular Biology CORE, Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5416-5383","authenticated-orcid":false,"given":"Florian","family":"Castet","sequence":"additional","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp K","family":"Haber","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0288-6314","authenticated-orcid":false,"given":"Roser","family":"Pinyol","sequence":"additional","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Torres-Martin","sequence":"additional","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3309-6200","authenticated-orcid":false,"given":"Laura","family":"Torrens","sequence":"additional","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agavni","family":"Mesropian","sequence":"additional","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[{"name":"Sema4, Stamford, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Puigvehi","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Hepatology Section, Gastroenterology Department, Consorci Parc de Salut Mar, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Maeda","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Qiang","family":"Leow","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Department of Anatomical Pathology, Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Harrod","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Royal Surrey County Hospital, Guildford, UK"},{"name":"University of Surrey, Guildford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Taik","sequence":"additional","affiliation":[{"name":"Sema4, Stamford, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigjidsuren","family":"Chinburen","sequence":"additional","affiliation":[{"name":"Hepato-Pancreatico-Biliary Surgery Department, National Cancer Center, Ulaanbaatar, Mongolia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdenebileg","family":"Taivanbaatar","sequence":"additional","affiliation":[{"name":"Hepato-Pancreatico-Biliary Surgery Department, National Cancer Center, Ulaanbaatar, Mongolia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkhbold","family":"Chinbold","sequence":"additional","affiliation":[{"name":"Hepato-Pancreatico-Biliary Surgery Department, National Cancer Center, Ulaanbaatar, Mongolia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Sol\u00e9 Arqu\u00e9s","sequence":"additional","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Donovan","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swan","family":"Thung","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Neely","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb, Princeton, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mazzaferro","sequence":"additional","affiliation":[{"name":"Gastrointestinal Surgery and Liver Transplantation Unit, National Cancer Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Anderson","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb, Princeton, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Roayaie","sequence":"additional","affiliation":[{"name":"Department of Surgery, White Plains Hospital Center, White Plains, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-6195","authenticated-orcid":false,"given":"Scott L","family":"Friedman","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Uzilov","sequence":"additional","affiliation":[{"name":"Sema4, Stamford, Connecticut, USA"},{"name":"Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9000-611X","authenticated-orcid":false,"given":"Daniela","family":"Sia","sequence":"additional","affiliation":[{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-2667","authenticated-orcid":false,"given":"Josep M","family":"Llovet","sequence":"additional","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, Universitat de Barcelona, Barcelona, Spain"},{"name":"Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Instituci\u00f3 Catalana De Recerca i Estudis Avan\u00e7ats, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"2025090712275830000_72.1.129.1","doi-asserted-by":"crossref","first-page":"7:7","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025090712275830000_72.1.129.2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025090712275830000_72.1.129.3","article-title":"Immunotherapies for hepatocellular carcinoma","author":"Llovet","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"2025090712275830000_72.1.129.4","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025090712275830000_72.1.129.5","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","author":"Cheng","year":"2021","journal-title":"J Hepatol"},{"key":"2025090712275830000_72.1.129.6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4706"},{"key":"2025090712275830000_72.1.129.7","doi-asserted-by":"publisher","DOI":"10.1038\/S41568-020-0285-7"},{"key":"2025090712275830000_72.1.129.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.06.007"},{"key":"2025090712275830000_72.1.129.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1942"},{"key":"2025090712275830000_72.1.129.10","doi-asserted-by":"publisher","DOI":"10.1038\/nature14404"},{"key":"2025090712275830000_72.1.129.11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0074"},{"key":"2025090712275830000_72.1.129.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01519-1"},{"key":"2025090712275830000_72.1.129.13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2293"},{"key":"2025090712275830000_72.1.129.14","unstructured":"Haber PK , Torres\u2010Mart\u00edn M , Andreu-Oller C . Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma. Gastroenterology 2021."},{"key":"2025090712275830000_72.1.129.15","unstructured":"Montironi C , Castet F , Haber PK . Data from: inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. European genome phenome Archive. Available: https:\/\/ega-archive.org\/studies\/EGAS00001005364"},{"key":"2025090712275830000_72.1.129.16","unstructured":"Esteban-Fabr\u00f3 R , Willoughby CE , Piqu\u00e9\u2010Gili M . Data from: cabozantinib enhances anti-PD1 efficacy and elicits a neutrophil-based immune response in murine models: implications for human HCC. gene expression Omnibus. Available: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE174570"},{"key":"2025090712275830000_72.1.129.17","unstructured":"Ally A , Balasundaram M , Carlsen R . Data from: comprehensive and integrative genomic characterization of hepatocellular carcinoma. NCI genomic data commons, 2017. Available: https:\/\/portal.gdc.cancer.gov\/legacy-archive\/search\/f"},{"key":"2025090712275830000_72.1.129.18","unstructured":"Villanueva A , Portela A , Sayols S . Data from: DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. gene expression Omnibus, 2015. Available: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE63898"},{"key":"2025090712275830000_72.1.129.19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0742"},{"key":"2025090712275830000_72.1.129.20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2322"},{"key":"2025090712275830000_72.1.129.21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1089"},{"key":"2025090712275830000_72.1.129.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.046"},{"key":"2025090712275830000_72.1.129.23","doi-asserted-by":"crossref","unstructured":"Hsu C-L , D-L O , Bai L-Y . Data from: exploring markers of exhausted CD8 T cells to predict response to immune checkpoint inhibitor therapy for hepatocellular carcinoma. gene expression Omnibus, 2021. Available: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE140901","DOI":"10.1159\/000515305"},{"key":"2025090712275830000_72.1.129.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1497"},{"key":"2025090712275830000_72.1.129.25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8399"},{"key":"2025090712275830000_72.1.129.26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52760"},{"key":"2025090712275830000_72.1.129.27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3200"},{"key":"2025090712275830000_72.1.129.28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900778"},{"key":"2025090712275830000_72.1.129.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.02.008"},{"key":"2025090712275830000_72.1.129.30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900475"},{"key":"2025090712275830000_72.1.129.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13889-6"},{"key":"2025090712275830000_72.1.129.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0382-x"},{"key":"2025090712275830000_72.1.129.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.023"},{"key":"2025090712275830000_72.1.129.34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28638"},{"key":"2025090712275830000_72.1.129.35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2017.12.018","article-title":"Axin deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of \u03b2-catenin activation","volume":"68","author":"Abitbol","year":"2018","journal-title":"J Hepatol"},{"key":"2025090712275830000_72.1.129.36","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209824"},{"key":"2025090712275830000_72.1.129.37","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jhep.2021.01.017","article-title":"Expression of NKG2D ligands is downregulated by \u03b2-catenin signalling and associates with HCC aggressiveness","volume":"74","author":"Cadoux","year":"2021","journal-title":"J Hepatol"},{"key":"2025090712275830000_72.1.129.38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"2025090712275830000_72.1.129.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03362-0"},{"key":"2025090712275830000_72.1.129.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.026"},{"key":"2025090712275830000_72.1.129.41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000515305","article-title":"Exploring markers of exhausted CD8 T cells to predict response to immune checkpoint inhibitor therapy for hepatocellular carcinoma","volume":"10","author":"Hsu","year":"2021","journal-title":"Liver Cancer"},{"key":"2025090712275830000_72.1.129.42","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00995-8"},{"key":"2025090712275830000_72.1.129.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.12.028"},{"key":"2025090712275830000_72.1.129.44","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1741"},{"key":"2025090712275830000_72.1.129.45","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3509"},{"key":"2025090712275830000_72.1.129.46","doi-asserted-by":"publisher","DOI":"10.1172\/jci123360"},{"key":"2025090712275830000_72.1.129.47","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1172\/JCI131234","article-title":"Methylation of immune synapse genes modulates tumor immunogenicity","volume":"130","author":"Berglund","year":"2020","journal-title":"J Clin Invest"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2021-325918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:28:22Z","timestamp":1757273302000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2021-325918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,7]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1136\/gutjnl-2021-325918"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2021-325918","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]}}}